Olema Pharmaceuticals, Inc. (OLMA) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts OLMA Hot Sheet
Join SI Premium – FREE
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q4 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI trade In focus, Iran sanctions loom - What’s moving markets
- Wolfe Research Upgrades PulteGroup (PHM) to Outperform
- BofA starts bullish Alvotech coverage on biosimilar launch cycle
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
